EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Combined BRAF/MEK inhibition for BRAF‑mutant melanoma brain metastases in pregnancy: A case report

Jaroslav Melus, Michaela Jezberova, Silvia Mikulajova, Katarina Komaromy Gerincova, Martin Karlik, Igor Straka, Marek Krivosik, Peter Valkovic, Gabriela Timarova

Oncology Letters · 24.10.2025 · 31 (1) · 1-8

DOI: 10.3892/ol.2025.15361 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Oncology Letters, online erschienen am 24.10.2025. Verfasst von Jaroslav Melus und 8 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Neurology, Comenius University Bratislava, Faculty of Medicine, University Hospital Bratislava, Bratislava 833 05, Slovakia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is a highly aggressive malignancy with the potential to metastasize to the placenta and fetus. Pregnancy-associated melanoma (PAM) complicated by brain metastases (MTS) is exceedingly rare, and its management requires balancing maternal survival with fetal safety. A 35-year-old pregnant woman with a history of superficial spreading melanoma presented at 24 weeks of gestation with multiple brain MTS. Following multidisciplinary consultation and after obtaining informed consent, two symptomatic brain MTS were surgically resected during pregnancy. Histopathology and immunohistochemistry confirmed metastatic melanoma, and molecular testing identified a B-Raf proto-oncogene serine/threonine kinase V600E mutation. Due to disease progression, targeted therapy with dabrafenib and trametinib was initiated in the third trimester. At 33 weeks of gestation, an acute cesarean section was performed following a focal impaired consciousness seizure. A premature male neonate was delivered, requiring respiratory support and intensive care. Following stabilization, the growth and psychomotor development of the neonate remained normal at follow-up. Postpartum, the mother transitioned to immune checkpoint inhibitor therapy and remains alive with partial remission 16 months after the diagnosis of brain MTS. The present case demonstrates the feasibility of combined neurosurgical and targeted therapeutic approaches for PAM with brain MTS. The case provides valuable clinical and ethical insights into individualized decision-making when managing advanced melanoma during pregnancy, a scenario that remains rare and poorly documented.

Schlagwörter

Stichwörter der Autor:innen

BRAF V600E mutationD + TPAMbrain MTSneurosurgery

Autor:innen und Institutionen

  • 2nd Department of Neurology, Comenius University Bratislava, Faculty of Medicine, University Hospital Bratislava, Bratislava 833 05, Slovakia.
  • Department of Magnetic Resonance Imaging, Dr. Magnet Ltd., Bratislava 833 05, Slovakia.
  • Department of Neonatology, University Hospital Bratislava, Bratislava 833 05, Slovakia.
  • 1st Department of Obstetrics and Gynecology, Slovak Medical University, University Hospital Bratislava, Bratislava 833 05, Slovakia.
  • Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava 813 71, Slovakia.

Zitieren

APA

Melus, J., Jezberova, M., Mikulajova, S., Gerincova, K. K., Karlik, M., Straka, I., Krivosik, M., Valkovic, P., & Timarova, G. (2025). Combined BRAF/MEK inhibition for BRAF‑mutant melanoma brain metastases in pregnancy: A case report. Oncology Letters, 31(1), 1-8. https://doi.org/10.3892/ol.2025.15361

Vancouver

Melus J, Jezberova M, Mikulajova S, Gerincova KK, Karlik M, Straka I, et al. Combined BRAF/MEK inhibition for BRAF‑mutant melanoma brain metastases in pregnancy: A case report. Oncology Letters. 2025;31(1):1-8. doi:10.3892/ol.2025.15361

BibTeX
@article{Melus2025,
  author = {Melus, Jaroslav and Jezberova, Michaela and Mikulajova, Silvia and Gerincova, Katarina Komaromy and Karlik, Martin and Straka, Igor and Krivosik, Marek and Valkovic, Peter and Timarova, Gabriela},
  title = {Combined BRAF/MEK inhibition for BRAF‑mutant melanoma brain metastases in pregnancy: A case report},
  journal = {Oncology Letters},
  year = {2025},
  volume = {31},
  number = {1},
  pages = {1--8},
  doi = {10.3892/ol.2025.15361}
}
Kostenlos starten →